Aurobindo Pharma Ltd.
Search Company
  You can view the Income statement for the last 5 years.
ISIN No INE406A01037 52Wk High (Rs.) 1419 BV (Rs.) 562.21 FV (Rs.) 1.00
Bookclosure 08/08/2025 52Wk Low (Rs.) 1010 EPS (Rs.) 60.02 P/E (X) 18.98
Mkt Cap. (Rs. Cr.) 66,147.50 P/BV (X) 2.03 Div Yield (%) 0.00 Mkt Lot 1
 
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)29.9733.3521.0024.8353.13
Diluted EPS (Rs.)29.9733.3521.0024.8353.13
Cash EPS (Rs.)35.1937.7028.4331.9261.46
Book Value[Excl.RevalReserv]/Share (Rs.)353.55336.62305.75292.15271.80
Book Value[Incl.RevalReserv]/Share (Rs.)353.55336.62305.75292.15271.80
Dividend / Share (Rs.)0.004.503.009.004.00
Revenue From Operations / Share (Rs.)188.25181.70218.34192.65270.07
PBDIT / Share (Rs.)49.6848.4736.9536.6080.38
PBIT / Share (Rs.)44.5744.1329.5229.5172.05
PBT / Share (Rs.)40.6141.0127.5527.9571.57
Net Profit / Share (Rs.)30.0833.3521.0024.8353.13
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)26.3926.6716.9218.9929.76
PBIT Margin (%)23.6724.2813.5115.3126.67
PBT Margin (%)21.5722.5712.6114.5026.49
Net Profit Margin (%)15.9718.359.6112.8819.67
Return on Networth / Equity (%)8.509.906.868.4919.54
Return on Capital Employeed (%)12.2712.989.479.9225.69
Return On Assets (%)6.347.764.936.7313.42
Long Term Debt / Equity (X)0.010.000.000.000.00
Total Debt / Equity (X)0.220.140.230.100.24
Asset Turnover Ratio (%)0.410.420.540.500.74
      
LIQUIDITY RATIOS     
      
Current Ratio (X)1.201.381.462.351.83
Quick Ratio (X)0.830.920.831.551.12
Inventory Turnover Ratio (X)4.631.771.941.411.58
Dividend Payout Ratio (NP) (%)0.0013.4935.7118.127.52
Dividend Payout Ratio (CP) (%)0.0011.9326.3814.106.50
Earning Retention Ratio (%)0.0086.5164.2981.8892.48
Cash Earning Retention Ratio (%)0.0088.0773.6285.9093.50
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)12.5415.5518.83126.59164.22
Interest Coverage Ratio (Post Tax) (%)8.5911.4111.7091.28109.54
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)71682.1166554.3834360.0540961.6255216.93
EV / Net Operating Revenue (X)6.566.252.693.633.49
EV / EBITDA (X)24.8423.4315.8719.1011.72
MarketCap / Net Operating Revenue (X)6.166.002.373.473.26
Retention Ratios (%)0.0086.5064.2881.8792.47
Price / BV (X)3.283.241.692.293.24
Price / Net Operating Revenue (X)6.166.002.373.473.26
EarningsYield0.020.030.040.030.06